Treated by Dr Bhavana
Advanced maternal age fertility issues affect women aged 35 and older in Kompally, Hyderabad, presenting unique challenges in conceiving due to declining egg quality and quantity. As women age, the ovarian reserve diminishes, chromosomal abnormalities increase, and pregnancy complications become more likely, requiring specialized reproductive care. Dr Bhavana, an experienced IVF Specialist, provides comprehensive fertility evaluation and advanced reproductive treatments tailored for women of advanced maternal age.
Reduction in the quantity and quality of remaining eggs in the ovaries, characterized by low anti-Müllerian hormone (AMH) levels and elevated follicle-stimulating hormone (FSH), making natural conception increasingly difficult with advancing age.
Progressive deterioration in egg quality leading to increased chromosomal abnormalities, higher miscarriage rates, and reduced fertilization potential, even when ovulation occurs regularly and menstrual cycles remain normal.
Development of age-associated reproductive conditions including fibroids, endometriosis, adenomyosis, and tubal factors that compound the challenges of conceiving naturally and may require additional interventions alongside fertility treatments.
Multiple factors can contribute to the development and progression of this condition.
Advanced Maternal Age Fertility Issues develops gradually. Recognising symptoms early gives you more treatment options.
From conservative to surgical — we always start with the least invasive option first.
A structured, patient-first approach from first visit to full recovery.
Dr Bhavana conducts comprehensive evaluation including detailed medical history, hormonal testing (AMH, FSH, estradiol), transvaginal ultrasound for ovarian reserve assessment, and partner semen analysis to understand the complete fertility picture and determine the most effective treatment approach.
Based on assessment results, age, ovarian reserve, and individual circumstances, Dr Bhavana develops a personalized treatment plan that may include ovulation induction, IUI, conventional IVF, or donor egg programs, with realistic success rate counseling and timeline expectations.
Dr Bhavana employs state-of-the-art IVF laboratory procedures including ICSI for optimal fertilization, extended embryo culture to blastocyst stage, preimplantation genetic testing to select chromosomally normal embryos, and vitrification for embryo preservation when needed.
Following successful embryo transfer, Dr Bhavana provides close monitoring with early pregnancy ultrasounds, hormonal support protocols, nutritional guidance, and coordinated obstetric care to optimize outcomes and manage any age-related pregnancy complications proactively.
What to expect at each phase of recovery.
Following egg retrieval or IUI procedures, most patients resume normal activities within 24-48 hours with mild cramping or bloating that resolves quickly. Rest is recommended on the day of the procedure, with gradual return to regular routine while avoiding strenuous exercise until pregnancy test.
The period between embryo transfer or IUI and pregnancy testing requires emotional support and patience. Progesterone supplementation continues, light activities are permitted, and patients are advised to maintain healthy lifestyle habits while avoiding pregnancy tests until the scheduled date to prevent false results.
Upon positive pregnancy test, close monitoring begins with serial beta-hCG blood tests to confirm appropriate hormone rise, followed by early ultrasounds at 6-7 weeks to visualize gestational sac and fetal heartbeat. Hormonal support continues through the first trimester with gradual transition to obstetric care.
With personalized IVF treatment, women aged 35-37 achieve pregnancy rates of 30-40% per cycle, while those 38-40 see rates of 20-30%, and women over 40 have 10-15% success with own eggs, significantly improving with donor egg programs which offer 50-60% success rates.
Preimplantation genetic testing for aneuploidy (PGT-A) significantly reduces miscarriage rates in women of advanced maternal age by selecting chromosomally normal embryos for transfer, decreasing pregnancy loss from 30-40% to approximately 10-15% in this age group.
With appropriate fertility treatment and close prenatal monitoring, women of advanced maternal age successfully carry pregnancies to term and deliver healthy babies. Dr Bhavana coordinates care with high-risk obstetric specialists to manage age-related pregnancy considerations and optimize maternal-fetal outcomes.
Many patients achieve their family-building goals through comprehensive fertility treatment, with options for embryo cryopreservation allowing future siblings from the same treatment cycle, and alternative pathways including donor programs ensuring multiple routes to parenthood.
Delaying fertility treatment in women of advanced maternal age results in further decline in ovarian reserve and egg quality, progressively reducing natural conception chances and assisted reproduction success rates with each passing year. The risk of chromosomal abnormalities, miscarriage, and pregnancy complications increases substantially, while the window for using one's own eggs narrows rapidly after age 40, potentially limiting family-building options to donor egg programs or alternative pathways to parenthood.
Women aged 35-40 should consult a fertility specialist after 6 months of unsuccessful conception attempts, while those over 40 should seek evaluation immediately when planning pregnancy or after 3 months of trying. Earlier consultation is warranted for women with known reproductive health conditions, irregular menstrual cycles, previous miscarriages, family history of early menopause, or prior cancer treatment, as prompt intervention maximizes treatment success and preserves reproductive options.
Early treatment means more options and better outcomes. Book a consultation to understand your condition and explore the right path forward.
